Moderna Secures US Government Funding for Bird Flu Vaccine Development
Moderna secures US government funding to develop a vaccine for bird flu amid rising animal infections. With expertise in vaccine development, Moderna is a key player in combatting the virus. The funding will expedite research efforts to bring a vaccine to market, addressing the urgent public health concern of a potential bird flu outbreak.